Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism.
Sansone
V
V
Meola
G
G
Perani
D
D
Fazio
F
F
Garibotto
V
V
Cotelli
M
M
Cotelli
M
M
Vitelli
E
E
D001786:Blood Glucose / Q000378:metabolism*; D001921:Brain / Q000000981:diagnostic imaging* / Q000503:physiopathology; D002545:Brain Ischemia / Q000000981:diagnostic imaging / Q000503:physiopathology; D003937:Diagnosis, Differential; D004298:Dopamine / Q000502:physiology*; D004734:Energy Metabolism / Q000502:physiology*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008875:Middle Aged; D018908:Muscle Weakness / Q000000981:diagnostic imaging / Q000503:physiopathology; D009223:Myotonic Dystrophy / Q000000981:diagnostic imaging* / Q000503:physiopathology; D009460:Neurologic Examination; D009483:Neuropsychological Tests; D020734:Parkinsonian Disorders / Q000000981:diagnostic imaging* / Q000503:physiopathology; D049268:Positron-Emission Tomography; D013223:Statistics as Topic
D001786:Blood Glucose; D019788:Fluorodeoxyglucose F18; D004298:Dopamine